Referred to the House Committee on Energy and Commerce.
Establishes a National Plan for Epilepsy within the HHS Secretary to coordinate federal research, prevention, diagnosis, treatment, care, and data sharing. Creates an Advisory Council with federal and nonfederal members, requires periodic public meetings, biennial Council reports, annual HHS assessments and reports to Congress, and a sunset date of December 31, 2035.
Supporters focus on research, equity, and coordination benefits
Technocratic, noncontroversial health coordination measure with likely bipartisan appeal and no explicit new spending.
Establishes a National Plan for Epilepsy within the HHS Secretary to coordinate federal research, prevention, diagnosis, treatment, care, and data sharing.
Creates an Advisory Council with federal and nonfederal members, requires periodic public meetings, biennial Council reports, annual HHS assessments and reports to Congress, and a sunset date of December 31, 2035.
The Secretary must solicit public comment, coordinate across agencies and internationally, and perform annual progress assessments.
Low‑controversy, administratively focused bill with sunset and stakeholder features; main barrier is procedural timing and lack of dedicated funding.
How solid the drafting looks.
Supporters focus on research, equity, and coordination benefits
These are examples from the analysis, not a ranked list of the most-affected groups.
Supporters focus on research, equity, and coordination benefits
Generally strongly supportive.
The bill creates coordinated federal leadership, prioritizes research, health equity, data improvements, and public engagement to reduce disparities and improve outcomes for people with epilepsy.
Mostly supportive but pragmatic.
Praises coordination and accountability yet will seek clarity on costs, measurable outcomes, and avoidance of redundant bureaucracy.
Wants clear implementation plans and funding sources.
Cautiously skeptical.
Supports research and better care in principle but concerned about expanding federal bureaucracy, unclear costs, and mandates on data sharing and interagency coordination.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Low‑controversy, administratively focused bill with sunset and stakeholder features; main barrier is procedural timing and lack of dedicated funding.
The bill has not accumulated any surfaced votes yet.
Supporters focus on research, equity, and coordination benefits
Low‑controversy, administratively focused bill with sunset and stakeholder features; main barrier is procedural timing and lack of dedicate…
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for National Plan for Epilepsy Act.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.